Minot Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $4.37M | Buy |
56,800
+30,875
| +119% | +$2.38M | 1.12% | 27 |
|
2022
Q1 | $1.89M | Buy |
25,925
+16,853
| +186% | +$1.23M | 0.41% | 57 |
|
2021
Q4 | $566K | Sell |
9,072
-13,645
| -60% | -$851K | 0.11% | 120 |
|
2021
Q3 | $1.34M | Buy |
22,717
+299
| +1% | +$17.7K | 0.29% | 74 |
|
2021
Q2 | $1.51M | Buy |
22,418
+2,012
| +10% | +$136K | 0.33% | 73 |
|
2021
Q1 | $1.29M | Sell |
20,406
-22,008
| -52% | -$1.39M | 0.33% | 75 |
|
2020
Q4 | $2.63M | Sell |
42,414
-5,515
| -12% | -$342K | 0.79% | 46 |
|
2020
Q3 | $2.89M | Buy |
47,929
+6,393
| +15% | +$385K | 1.09% | 38 |
|
2020
Q2 | $2.44M | Buy |
41,536
+34,620
| +501% | +$2.04M | 1.22% | 32 |
|
2020
Q1 | $385K | Buy |
6,916
+2,808
| +68% | +$156K | 0.28% | 82 |
|
2019
Q4 | $277K | Buy |
+4,108
| New | +$277K | 0.13% | 111 |
|